SCHEMBL7945543

SCHEMBL7945543

COc1cc([N+](=O)[O-])cc(Cl)c1OC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.52
HTT P42858 3/20 0.50
PTGS2 P35354 1/20 0.50
MAPT P10636 4/20 0.48
SMN1; SMN2 Q16637 4/20 0.48
HPGD P15428 3/20 0.48
LMNA P02545 3/20 0.48
ERN1 O75460 1/20 0.47
NPC1 O15118 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
RAB9A P51151 1/20 0.47
MAPK1 P28482 2/20 0.46
TDP1 Q9NUW8 1/20 0.45
HSD17B10 Q99714 1/20 0.44
PKM P14618 1/20 0.44
GPR35 Q9HC97 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2105879 0.89 ALDH1A1 (0.59) ALDH1A1HTTPTGS2MAPTSMN1; SMN2
SCHEMBL6313062 0.87 PTGS2 (0.62) ALDH1A1HTTPTGS2MAPTSMN1; SMN2
SCHEMBL30318939 0.84 HTT (0.45) ALDH1A1HTTMAPTSMN1; SMN2HPGD
SCHEMBL10985004 0.84 ALDH1A1 (0.64) ALDH1A1HTTPTGS2MAPTSMN1; SMN2
SCHEMBL2100704 0.82 ALDH1A1 (0.52) ALDH1A1HTTPTGS2MAPTSMN1; SMN2
SCHEMBL10981831 0.81 HTT (0.56) ALDH1A1HTTPTGS2MAPTSMN1; SMN2
SCHEMBL10716836 0.81 HTT (0.53) ALDH1A1HTTPTGS2MAPTSMN1; SMN2
SCHEMBL10882469 0.81 ALDH1A1 (0.67) ALDH1A1HTTMAPTSMN1; SMN2HPGD
SCHEMBL1437990 0.81 ERN1 (0.62) ALDH1A1HTTMAPTSMN1; SMN2HPGD
SCHEMBL14871877 0.81 ALDH1A1 (0.50) ALDH1A1HTTPTGS2MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235746-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATIVE AGENT CELLTECH THERAPEUTICS, LIMITED (GB) 2001-05-22 US disclosed
US-5958935-A Substituted 2-anilinopyrimidines useful as protein kinase inhibitors CELLTECH THERAPEUTICS LIMITED (GB) 1999-09-28 US disclosed
EP-0862560-A1 SUBSTITUTED 2-ANILINOPYRIMIDINES USEFUL AS PROTEIN KINASE INHIBITORS CELLTECH THERAPEUTICS LIMITED (GB) 1998-09-09 EP disclosed
WO-1997019065-A1 SUBSTITUTED 2-ANILINOPYRIMIDINES USEFUL AS PROTEIN KINASE INHIBITORS CELLTECH THERAPEUTICS LIMITED (GB) 1997-05-29 WO disclosed